Head-to-head · Cost-Efficiency Index
FeelGood vs Medsol RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
FeelGood
Cost-first shoppers who want a low compounded-injection entry price with an oral tablet alternative for needle-averse shoppers.
Visit FeelGoodMedsol RX
Shoppers who will actually commit to a 12-month prepay and want the lowest possible locked-in monthly rate.
Visit Medsol RXThe verdict
FeelGood and Medsol RX tie on the Cost-Efficiency Index at 65/100, so neither wins outright on the numbers. For most shoppers we'd start with FeelGood (ranked #162, a hair above #165) — Cost-first shoppers who want a low compounded-injection entry price with an oral tablet alternative for needle-averse shoppers. But Medsol RX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs FeelGood.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | FeelGood | Medsol RX |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 65/100 |
| Semaglutide / mo | Not disclosed | $199/mo (compounded) |
| Tirzepatide / mo | $149/mo (starting dose, compounded) | $259/mo (compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $3,108 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #162 | #165 |
FeelGood
65/100Where the value is
- Low advertised compounded-injection entry price ($149/mo) with no stated membership or hidden fees
- Oral/dissolvable tablet option available for needle-averse patients ($249/mo)
- Free shipping and HSA/FSA eligibility stated plainly on the homepage
The tradeoffs
- Per-dose pricing, states served, named medical director, and named compounding pharmacy are all gated behind the intake questionnaire — none are disclosed on the public site, so I could not independently verify them
- It is unclear from the public site whether tirzepatide is priced the same as semaglutide or separately
Medsol RX
65/100Where the value is
- Every commitment tier bundles a dedicated care coach, custom treatment plan, and medical oversight at no extra charge
- Genuine month-to-month option exists with no long-term lock-in, unlike some peers that require prepay
- HSA/FSA eligible with Klarna financing offered
The tradeoffs
- The eye-catching $129/$199 headline prices require a full 12-month prepay ($1,548-$2,388 charged upfront) — the flexible month-to-month rate is $199/$259, notably higher
- No compounding pharmacy is named — only a generic 'certified U.S. pharmacies' claim
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.